TET酶:参与癌症的发展和治疗前景
Tarik Aanniz1, Meriem El Fessikh2, Jihane Touhtouh3
1Medical Biotechnology Laboratory, Rabat Medical & Pharmacy School, Mohammed V University in Rabat, Rabat, B.P. 6203, Morocco.
Biochimica et biophysica acta. Gene regulatory mechanisms
|October 18, 2025
概括
TET酶家族调节DNA甲基化和表观遗传学. 它们的失调与癌症有关,这使得它们成为新的抗癌治疗的有希望的治疗点.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- TET (十一转位) 酶家族对于人类基因组中的动态DNA甲基化调节至关重要.
- TET酶氧化5-甲基细胞素 (5mC) 转化为基甲基化衍生物,使活性DNA脱甲基化并调节细胞过程.
研究的目的:
- 探索TET蛋白的多样性作用和调控机制.
- 检查TET蛋白失调如何导致癌症进展.
- 突出TET酶作为抗癌疗法的可用药物点的潜力.
主要方法:
- 关于TET酶功能,调节和参与癌症的研究的文献综述.
- 对与TET蛋白失调相关的表观遗传变化的分析.
- 检查针对TET酶的当前和新兴治疗策略.
主要成果:
- TET蛋白对于维持表观遗传稳定性和正常细胞功能至关重要.
- TET酶的失调与各种癌症的发展和进展有关.
- TET酶代表了针对新型癌症疗法的重要研究领域.
结论:
- 了解TET酶功能和失调,为癌症生物学提供了关键的见解.
- 向TET酶为开发有效的抗癌疗法提供了一个有希望的途径.
- 对TET蛋白的进一步研究可能会导致改善癌症预防和治疗策略.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K


